tiprankstipranks
Fusion Antibodies Plc (GB:FAB)
LSE:FAB
UK Market

Fusion Antibodies Plc (FAB) Cash flow

3 Followers

Fusion Antibodies Plc Cash Flow

GB:FAB's free cash flow for Q2 2023 was £―. For the 2023 fiscal year, GB:FAB's free cash flow was decreased by £-1.28M and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Operating Cash Flow
-£ -1.75M£ -325.00K£ -1.14M£ -160.00K£ -1.10M
Investing Cash Flow
-£ -111.00K£ -257.00K£ -362.00K£ -103.00K£ -1.37M
Financing Cash Flow
-£ 3.00K£ -55.00K£ 2.65M£ -184.00K£ -41.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 195.00K£ 2.05M£ 2.69M£ 1.54M£ 1.98M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--£ 116.00K£ 2.81M£ 0.00£ 0.00
Issuance Of Debt
-£ 7.00K£ -162.00K£ -150.00K£ 0.00-
Repayment Of Debt
-£ -82.00K£ -162.00K£ -164.00K£ -172.00K£ -37.00K
Free Cash Flow
-£ -1.87M£ -583.00K£ -1.14M£ -269.00K£ -2.48M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

Fusion Antibodies Plc Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis